Grown Rogue International (GRUSF) Notes Payables (2012 - 2026)
Grown Rogue International's (GRUSF) quarterly Notes Payables came in at $70664.0 in Q1 2026, down 99.03% year-on-year from $7.3 million in Q1 2025, and down 48.44% quarter-over-quarter from $137041.0 in Q4 2025.
Grown Rogue International (GRUSF) Notes Payables (2012 - 2026) Analysis & Trends
Grown Rogue International's Notes Payables history runs 15 years deep, the most recent figure standing at $70664.0 for Q1 2026.
- On a quarterly basis, Notes Payables fell 99.03% year-over-year to $70664.0 in Q1 2026; TTM through Mar 2026 was $70664.0, a 99.03% decrease from a year earlier, with the FY2025 full-year figure at $137041.0, down 98.9% from the prior year.
- Notes Payables slipped to $70664.0 in Q1 2026 per GRUSF's latest filing, from $137041.0 in the prior quarter.
- Across five years, Notes Payables topped out at $144.0 billion in Q3 2025 and bottomed at $70664.0 in Q1 2026.
- The 5-year median for Notes Payables is $6.4 million (2023), against an average of $10.3 billion.
- Across the five-year window, Notes Payables jumped 1485696.7% in 2025 and slumped 99.03% in 2026, its largest moves.
- Year by year, Notes Payables stood at $300000.0 in 2022, then jumped by 1729.37% to $5.5 million in 2023, then surged by 127.84% to $12.5 million in 2024, then plunged by 98.9% to $137041.0 in 2025, then tumbled by 48.44% to $70664.0 in 2026.
- Per Business Quant, the three latest GRUSF Notes Payables figures stand at $70664.0 (Q1 2026), $137041.0 (Q4 2025), and $144.0 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,664.00 |
| Dec 31, 2025 | 137,041.00 |
| Sep 30, 2025 | 144.02 Bn |
| Jun 30, 2025 | 119,778.00 |
| Mar 31, 2025 | 7.32 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Sep 30, 2024 | 9.69 Mn |
| Jun 30, 2024 | 10.09 Mn |
| Mar 31, 2024 | 12.54 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Oct 31, 2023 | 7.81 Mn |
| Apr 30, 2023 | 992,560.00 |
| Jan 31, 2023 | 721,849.00 |
| Oct 31, 2022 | 300,000.00 |
| Oct 31, 2021 | 162,899.00 |
| Jan 31, 2021 | 930,195.00 |
| Oct 31, 2020 | 583,390.00 |
| Jul 31, 2020 | 697,381.00 |
| Apr 30, 2020 | 242,599.00 |
| Jan 31, 2020 | 248,633.00 |